Utah Retirement Systems Abbott Laboratories Transaction History

Utah Retirement Systems

$8.7 Billion
Q3 2024

A detailed history of Utah Retirement Systems transactions in Abbott Laboratories stock. As of the latest transaction made, Utah Retirement Systems holds 286,346 shares of ABT stock, worth $32.7 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

286,346

Previous 285,046 0.46%

Holding current value

$32.7 Million

Previous $29.6 Million 10.22%

% of portfolio

0.38%

Previous 0.36%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $130,090 - $153,569	1,300 Added 0.46%	286,346 $32.6 Million
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $1.52 Million - $1.7 Million	-15,100 Reduced 5.03%	285,046 $29.6 Million
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $32,856 - $36,288	-300 Reduced 0.1%	300,146 $34.1 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $180,380 - $220,800	2,000 Added 0.67%	300,446 $33.1 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $114,636 - $137,544	1,200 Added 0.4%	298,446 $28.9 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $836,474 - $932,007	-8,300 Reduced 2.72%	297,246 $32.4 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $87,174 - $102,609	900 Added 0.3%	305,546 $30.9 Million
Q4 2022 Feb 15, 2023	SELL	$95.06 - $111.52 $266,168 - $312,256	-2,800 Reduced 0.91%	304,646 $33.5 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $145,140 - $168,045	1,500 Added 0.49%	307,446 $29.7 Million
Q2 2022 Aug 16, 2022	SELL	$102.07 - $123.37 $418,487 - $505,817	-4,100 Reduced 1.32%	305,946 $33.2 Million
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $581,502 - $709,104	-5,100 Reduced 1.62%	310,046 $36.7 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $80,871 - $99,022	700 Added 0.22%	315,146 $44.4 Million
Q3 2021 Nov 16, 2021	SELL	$116.66 - $129.06 $1.95 Million - $2.16 Million	-16,700 Reduced 5.04%	314,446 $37.1 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $105,790 - $124,530	-1,000 Reduced 0.3%	331,146 $38.4 Million
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $1.58 Million - $1.86 Million	-14,500 Reduced 4.18%	332,146 $39.8 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $1.55 Million - $1.69 Million	14,800 Added 4.46%	346,646 $38 Million
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $210,772 - $255,967	2,300 Added 0.7%	331,846 $36.1 Million
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $76,570 - $98,000	1,000 Added 0.3%	329,546 $30.1 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $6,282 - $9,186	-100 Reduced 0.03%	328,546 $25.9 Million
Q4 2019 Feb 12, 2020	BUY	$78.51 - $87.4 $94,212 - $104,880	1,200 Added 0.37%	328,646 $28.5 Million
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $147,312 - $159,732	1,800 Added 0.55%	327,446 $27.4 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $169,737 - $197,965	2,329 Added 0.72%	325,646 $27.4 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $276,269 - $334,010	4,172 Added 1.31%	323,317 $25.8 Million
Q4 2018 Feb 08, 2019	BUY	$65.56 - $74.27 $45,892 - $51,989	700 Added 0.22%	319,145 $23.1 Million
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $91,215 - $110,040	1,500 Added 0.47%	318,445 $23.4 Million
Q2 2018 Aug 10, 2018	BUY	$57.57 - $63.54 $97,869 - $108,018	1,700 Added 0.54%	316,945 $19.3 Million
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $28,135 - $31,810	500 Added 0.16%	315,245 $18.9 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $230,824 - $247,121	4,300 Added 1.39%	314,745 $18 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $14.9 Million - $16.7 Million	310,445	310,445 $16.6 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Utah Retirement Systems with notifications on news.

Account

Utah Retirement Systems Abbott Laboratories Transaction History